52 results
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
18 Dec 23
Third party tender offer statement (amended)
6:59am
, transaction costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
4 Dec 23
Third party tender offer statement (amended)
7:04am
costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
17 Nov 23
Third party tender offer statement (amended)
6:53am
costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
15 Nov 23
Third party tender offer statement (amended)
6:51am
, transaction costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially
SC TO-T/A
EX-99
ttd879
8 Nov 23
Third party tender offer statement (amended)
5:06pm
SC 14D9
5ztc952p04jrf zqty
13 Oct 23
Tender offer solicitation
7:11am
SC TO-T
EX-99
fvn04cs
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
542ghe9k
13 Oct 23
Third party tender offer statement
6:52am
SC TO-C
bkv53oewm60sp 39
3 Oct 23
Information about tender offer
4:30pm
SC TO-C
EX-99.1
18ckq22f2wxubp
3 Oct 23
Information about tender offer
4:30pm
SC14D9C
EX-99.4
1j3p9q
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-2.1
dbpctnxkutth0oev1tdc
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-2.1
exd93br 3w3jr
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.4
vb38cukqv5amjcn6i
3 Oct 23
Tender and Support Agreement
7:35am
ARS
br5fcbzr
1 May 23
Annual report to shareholders
1:52pm